Chauvin sales rise thanks to foreign acquisitions:
This article was originally published in Clinica
Executive Summary
Sales at French ophthalmology company Chauvin were up 68% to Fr 582 million ($120 million) in 1994 compared with the previous year. This includes sales from Smith & Nephew's (UK) ophthalmic division and Ankerpharm (Germany), which Chauvin purchased last year. Excluding these, sales were up 12.5% on 1993 figures. Consolidated profits remained flat at Fr 36 million. Excluding goodwill amortisation of the acquisitions, net profit rose 41% to Fr 52 million. Foreign sales increased during the year, with almost half the company's revenues coming from outside France, compared with just 20% in 1991. Chauvin expects a 5% growth in turnover in 1995.